195 related articles for article (PubMed ID: 32601196)
1. A tumor-associated splice-isoform of
Ray D; Yun YC; Idris M; Cheng S; Boot A; Iain TBH; Rozen SG; Tan P; Epstein DM
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16391-16400. PubMed ID: 32601196
[TBL] [Abstract][Full Text] [Related]
2. RNA Splicing of the Abi1 Gene by MBNL1 contributes to macrophage-like phenotype modulation of vascular smooth muscle cell during atherogenesis.
Li Y; Guo X; Xue G; Wang H; Wang Y; Wang W; Yang S; Ni Q; Chen J; Lv L; Zhao Y; Ye M; Zhang L
Cell Prolif; 2021 May; 54(5):e13023. PubMed ID: 33759281
[TBL] [Abstract][Full Text] [Related]
3. Tumorigenic de-differentiation: the alternative splicing way.
Ray D; Epstein DM
Mol Cell Oncol; 2020 Sep; 7(6):1809959. PubMed ID: 33235913
[TBL] [Abstract][Full Text] [Related]
4. The Alternative Splicing Factor, MBNL1, Inhibits Glioblastoma Tumor Initiation and Progression by Reducing Hypoxia-Induced Stemness.
Voss DM; Sloan A; Spina R; Ames HM; Bar EE
Cancer Res; 2020 Nov; 80(21):4681-4692. PubMed ID: 32928918
[TBL] [Abstract][Full Text] [Related]
5. Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity.
Terenzi F; Ladd AN
RNA Biol; 2010; 7(1):43-55. PubMed ID: 20009516
[TBL] [Abstract][Full Text] [Related]
6. Alternatively spliced MBNL1 isoforms exhibit differential influence on enhancing brown adipogenesis.
Hung CS; Lin JC
Biochim Biophys Acta Gene Regul Mech; 2020 Jan; 1863(1):194437. PubMed ID: 31730826
[TBL] [Abstract][Full Text] [Related]
7. Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms.
Tran H; Gourrier N; Lemercier-Neuillet C; Dhaenens CM; Vautrin A; Fernandez-Gomez FJ; Arandel L; Carpentier C; Obriot H; Eddarkaoui S; Delattre L; Van Brussels E; Holt I; Morris GE; Sablonnière B; Buée L; Charlet-Berguerand N; Schraen-Maschke S; Furling D; Behm-Ansmant I; Branlant C; Caillet-Boudin ML; Sergeant N
J Biol Chem; 2011 May; 286(18):16435-46. PubMed ID: 21454535
[TBL] [Abstract][Full Text] [Related]
8. The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1.
Welte T; Tuck AC; Papasaikas P; Carl SH; Flemr M; Knuckles P; Rankova A; Bühler M; Großhans H
Genes Dev; 2019 Sep; 33(17-18):1221-1235. PubMed ID: 31371437
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.
Dhaenens CM; Schraen-Maschke S; Tran H; Vingtdeux V; Ghanem D; Leroy O; Delplanque J; Vanbrussel E; Delacourte A; Vermersch P; Maurage CA; Gruffat H; Sergeant A; Mahadevan MS; Ishiura S; Buée L; Cooper TA; Caillet-Boudin ML; Charlet-Berguerand N; Sablonnière B; Sergeant N
Exp Neurol; 2008 Apr; 210(2):467-78. PubMed ID: 18177861
[TBL] [Abstract][Full Text] [Related]
10. Autoregulated splicing of muscleblind-like 1 (MBNL1) Pre-mRNA.
Gates DP; Coonrod LA; Berglund JA
J Biol Chem; 2011 Sep; 286(39):34224-33. PubMed ID: 21832083
[TBL] [Abstract][Full Text] [Related]
11. The Regulatory Role of Both MBNL1 and MBNL1-AS1 in Several Common Cancers.
Zhang Q; Wu Y; Chen J; Tan F; Mou J; Du Z; Cai Y; Wang B; Yuan C
Curr Pharm Des; 2022; 28(7):581-585. PubMed ID: 34459372
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial mutagenesis of MBNL1 zinc fingers elucidates distinct classes of regulatory events.
Purcell J; Oddo JC; Wang ET; Berglund JA
Mol Cell Biol; 2012 Oct; 32(20):4155-67. PubMed ID: 22890842
[TBL] [Abstract][Full Text] [Related]
13. FMRP deficiency leads to multifactorial dysregulation of splicing and mislocalization of MBNL1 to the cytoplasm.
Jung S; Shah S; Han G; Richter JD
PLoS Biol; 2023 Dec; 21(12):e3002417. PubMed ID: 38048343
[TBL] [Abstract][Full Text] [Related]
14. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
Dansithong W; Paul S; Comai L; Reddy S
J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
[TBL] [Abstract][Full Text] [Related]
15. The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing.
Warf MB; Diegel JV; von Hippel PH; Berglund JA
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9203-8. PubMed ID: 19470458
[TBL] [Abstract][Full Text] [Related]
16. The SRSF3-MBNL1-Acin1 circuit constitutes an emerging axis to lessen DNA fragmentation in colorectal cancer via an alternative splicing mechanism.
Chen YS; Liu CW; Lin YC; Tsai CY; Yang CH; Lin JC
Neoplasia; 2020 Dec; 22(12):702-713. PubMed ID: 33142236
[TBL] [Abstract][Full Text] [Related]
17. Widespread JNK-dependent alternative splicing induces a positive feedback loop through CELF2-mediated regulation of MKK7 during T-cell activation.
Martinez NM; Agosto L; Qiu J; Mallory MJ; Gazzara MR; Barash Y; Fu XD; Lynch KW
Genes Dev; 2015 Oct; 29(19):2054-66. PubMed ID: 26443849
[TBL] [Abstract][Full Text] [Related]
18. MBNL1 alternative splicing isoforms play opposing roles in cancer.
Tabaglio T; Low DH; Teo WKL; Goy PA; Cywoniuk P; Wollmann H; Ho J; Tan D; Aw J; Pavesi A; Sobczak K; Wee DKB; Guccione E
Life Sci Alliance; 2018 Oct; 1(5):e201800157. PubMed ID: 30456384
[TBL] [Abstract][Full Text] [Related]
19. A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I.
Zhang F; Bodycombe NE; Haskell KM; Sun YL; Wang ET; Morris CA; Jones LH; Wood LD; Pletcher MT
Hum Mol Genet; 2017 Aug; 26(16):3056-3068. PubMed ID: 28535287
[TBL] [Abstract][Full Text] [Related]
20. Requirements for PKC-augmented JNK activation by MKK4/7.
Lopez-Bergami P; Ronai Z
Int J Biochem Cell Biol; 2008; 40(5):1055-64. PubMed ID: 18182317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
